Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;69(9):2612-2618.
doi: 10.1111/jgs.17274. Epub 2021 May 14.

Physician survey regarding updated PCV13 vaccine recommendations for adults ≥65 years

Affiliations

Physician survey regarding updated PCV13 vaccine recommendations for adults ≥65 years

Laura P Hurley et al. J Am Geriatr Soc. 2021 Sep.

Abstract

Background: In June 2019, the Advisory Committee on Immunization Practices recommended discontinuing the routine use of the pneumococcal conjugate vaccine (PCV13) among adults aged ≥65 years and instead recommended PCV13 be used based on shared clinical decision making (SCDM).

Objectives: We wanted to assess among primary care physicians (1) knowledge and attitudes regarding the new SCDM PCV13 recommendation and (2) how the new recommendation will affect their likelihood of recommending PCV13 to adults aged ≥65 years.

Design: This was done by mail and internet-based survey, which was conducted October 2019 through January 2020. The study was carried out on a nationally representative sample of general internists (GIMs) and family physicians (FPs).

Results: The response rate was 64% (617/968, GIM 57%, FP 71%). Only 41% of respondents were aware of the SCDM PCV13 recommendation in adults aged ≥65 years; 76% agreed (37% "Strongly," 39% "Somewhat") that their patients aged ≥65 years will get confused by having a SCDM recommendation for PCV13 and a routine recommendation for the pneumococcal polysaccharide vaccine (PPSV23); 60% agreed (18% "Strongly," 42% "Somewhat") that they were unsure of what points to emphasize when having a SCDM conversation with an adult aged ≥65 years about receiving PCV13. Just over 50% reported they would be less likely to recommend PCV13 for adults aged ≥65 years as a result of the new recommendation, but 42% reported that their recommendation for PCV13 would not change.

Conclusions: Word of the new ACIP recommendation for PCV13 for adults aged ≥65 years needs to be further disseminated. Investigation into why some physicians do not plan to change their recommendations is warranted.

Keywords: Advisory Committee on Immunization Practices; older adults; pneumococcal vaccines; primary care physicians.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

None of the authors has any conflict of interest.

Figures

FIGURE 1
FIGURE 1
Physician attitudes regarding updated PCV13 vaccine recommendations for adults aged ≥65 years, United States, 2019–2020 (n = 617). *p < 0.05 for comparison between family physicians and general internists (Chi-square test) with general internists being more likely to agree. Some percentages do not add up to 100% due to rounding
FIGURE 2
FIGURE 2
How will these new ACIP recommendations affect the way you recommend PCV13 to adults age ≥65 years? (n = 617). ACIP, Advisory Committee on Immunization Practices

References

    1. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network, Streptococcus pneumoniae; 2018. https://www.cdc.gov/abcs/reports-findings/survreports/spneu18.pdf. Accessed September 25, 2020.
    1. National Foundation for Infectious Diseases. Pneumococcal Disease and Older Adults; 2020. https://www.nfid.org/infectious-diseases/pneumococcal-disease-and-older-.... Accessed September 25, 2020.
    1. Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373(5):415–427. - PMC - PubMed
    1. Centers for Disease Control (CDC). Adult immunization. Recommendations of the immunization practices advisory committee (ACIP). MMWR Morb Mortal Wkly Rep. 1984;33 (Suppl 1):1S–68S. - PubMed
    1. Tomczyk S, Bennett NM, Stoecker C, et al. Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63(37):822–825. - PMC - PubMed

Publication types

Substances